Method of treating gout by topical application of nano liniment

Abstract

A method of treating gout in a patient is provided. The method comprises topically applying to a gout-affected area of the patient an external nano liniment comprising a cream phase and nanoparticles dispersed in the cream phase. The nanoparticles have a coating structure comprising a water phase, an oil phase and a water phase in sequence from inside to outside. Active ingredients for treating gout are embedded or dispersed in the water phase and/or the oil phase of the nanoparticles, and a particle size distribution of the nanoparticles is in a range of 1-200 nm. The topical application reduces uric acid levels in blood, dissolves gout crystals, and relieves symptoms including joint redness, swelling, hotness, and pain while avoiding systemic side effects associated with oral administration of gout medications.

Dependencies are inferred from the claim text.